inVentiv to provide team for Keltman

inVentiv Selling Solutions, will begin providing a sales personnel to Keltman Pharmaceuticals, a wholesale pharmaceutical company specializing in re-packaged medications for physician dispensing.

The inVentiv sales team will complement Keltman's in-house sales force by maintaining in-office, medicine dispensing systems for physicians. Officials at inVentiv note that the point-of-care program will enable physicians to customize a formulary of pre-packaged prescription drugs that can be dispensed to patients while they are in the office.

Paul Mignon, president of inVentiv Selling Solutions, said: “The ways in which sales representatives add value to the patient-physician relationship are continuing to evolve. As the Keltman model demonstrates, some representatives are becoming a key link in directly supporting patient access to medicine.”

Wyatt Waltman, co-founder and CEO of Keltman Pharmaceuticals, said that his company is currently in a growth mode and was looking for the best way to maximize the transition from a contractor-based rep model to more of a fulltime rep model. “When we looked at the fastest and best way to do that, it was to partner with inVentiv. That was really our best and most effective way to grow quickly.”

Keltman Pharmaceuticals is a full-service provider focused on bringing innovative practice solutions to enhance patient care and creating alternative revenue sources for physicians. Keltman is accredited by the National Association Boards of Pharmacy.

InVentiv Health provides customized clinical, sales, marketing and communications solutions through its four core business segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial and inVentiv Patient Outcomes.

Its client roster is comprised of more than 350 pharmaceutical, biotech, life sciences and healthcare payer companies.
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters

What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.

A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.